GSK divests rare disease gene therapy drugs to Orchard Therapeutics – WHTC
WHTC |
GSK divests rare disease gene therapy drugs to Orchard Therapeutics
WHTC FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera/File Photo. LONDON (Reuters) – GlaxoSmithKline said on Thursday is was transferring its rare disease gene therapy drugs to … GSK To Transfer Rare Disease Gene Therapies To Orchard; Takes 19.9% Equity Stake |
